The news comes after an expert panel of authorities met with representative leading vaccine makers from the country to devise a framework around vaccine distribution in the country, going forward. The trials will be conducted in 10 centres at first, following which authorities plan to set up more centres across the country’s length and breadth.
Pune-based SII, owned by conglomerate Adar Poonawalla, which has promised to produce over a hundred million doses of the vaccine is already in the middle of ramping up production facilities. The vaccine company is also in talks with private firms and philanthropists to raise funds for the same. Serum Institute will also be receiving close to $150 million ‘at-risk’ funding from Bill and Melinda Gates Foundation to develop a low-cost, readily available doses for populations at large which will be routed through GAVI.